Arimidex
information and resources from the National Cancer Institute
Arimidex
(Other name for: anastrozole)Aromasin
(Other name for: exemestane)Arimidex
(Other name for: anastrozole)
anastrozole
Accel. Approv. (clinical benefit not established) for the adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer
AstraZeneca Sep 05 2002
anastrozole
For first-line treatment of postmenopausal women with hormone receptor positive or hormone receptor unknown locally advanced or metastatic breast cancer.
AstraZeneca Pharmaceuticals Sep 01 2000
anastrozole
Treatment of advanced breast cancer in postmenopausal women with disease progression following tamoxifen therapy.
AstraZeneca Pharmaceuticals Dec 27 1995
|
|
|
|
news articles
AstraZeneca To Face Arimidex Sales Erosion Mar 20, 2006
newratings.com 0914 GMT [Dow Jones] Novartis' (NVS) decision to start a head-to-head study of breast cancer drug Femara against AstraZeneca's (AZN) Arimidex would mean an ...
Switching to Arimidex® Reduces Need for Invasive Diagnostic ... Mar 9, 2006
Cancer Consultants (press release), ...breast cancer patients with uterine abnormalities related to Nolvadex® (tamoxifen), switching to the aromatase inhibitor Arimidex® (anastrozole) reduced the ...
A 62-Year-Old Woman With a New Diagnosis of Breast Cancer Mar 21, 2006
Journal of American Medical Association (subscription), The Arimidex, Tamoxifen, Alone or in Combination (ATAC) trial was the first study to report results, is the largest to date, and provides the longest follow-up ...
Novartis to compare cancer drug Femara with AstraZeneca drug Mar 20, 2006
MarketWatch AG (NVS) said Monday it has initiated a study that will compare its breast cancer drug Femara to the best-selling treatment of its class, Arimidex, which is ...
Los 10 artículos más citados en la literatura médica Mar 22, 2006
AZprensa, En el puesto 10 aparece el artículo publicado en The Lancet "Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 ...
Roche, Novartis Stronger On Positive News Mar 20, 2006
newratings.com Novartis from news that breast cancer drug Femara received German regulatory approval. Novartis plans a comparison study vs AstraZeneca's Arimidex. ...
Drug Company Fully Funds Cancer Drug Mar 20, 2006
newswire.co.nz, Early breast cancer patients will no longer have to pay part charges for their Arimidex prescriptions after the drugs manufacturer has decided to fully ...
3i, BAA, Prudential, AstraZeneca: UK, Irish Equity Preview Mar 19, 2006
Bloomberg AstraZeneca Plc (AZN LN): Novartis AG, Switzerland's biggest drugmaker, will test its Femara breast-cancer medicine against AstraZeneca's Arimidex, the current ...
Novartis wins German okay for broader Femara use Mar 19, 2006
Reuters Femara are appropriate, giving Novartis the opportunity to go after the market leader in the field, AstraZeneca Plc's (AZN.L: Quote, Profile, Research) Arimidex ...
PGA TOUR: Ames wins for charity at THE PLAYERS Championship Mar 27, 2006
noticias.info, ...a wide range of products that make significant contributions to treatment options and patient care including CRESTOR, NEXIUM, SEROQUEL, ARIMIDEX, and PULMICORT ...
Neoadjuvant Aromatase Inhibitors May Be as Effective as ... Mar 27, 2006
DG News Patients were randomised to pre-operative treatment with either an aromatase inhibitor -- consisting of either anastrazole (Arimidex) or exemestane (Aromasin ...
Updated Guidelines for Treatment of Ovarian Cancer Mar 27, 2006
Cancer Consultants (press release), The list of treatment options for recurrent ovarian cancer was broadened to include Arimidex® (anastrozole), Avastin® (bevacizumab), Camptosar® (ironotecan ...
Thwarting further breast cancer Mar 15, 2006
Sarasota Herald-Tribune, ...protein. Three new drugs -- Femara, Arimidex and Aromasin -- block the conversion of androgens (male hormones) into estrogen. The ...
New cancer drugs reduce recurrence Mar 6, 2006
Contra Costa Times, Three new drugs -- Femara, Arimidex and Aromasin -- block the conversion of androgens (male hormones) to estrogen. Women do make male hormones. ...
More Routine Monitoring of Bone Density, Preventive Management ... Mar 23, 2006
DG News ...cancer in various patient groups: healthy women; women who had received treatment for early breast cancer; and women enrolled in the Arimidex or Tamoxifen ...
Bench dedication to mark victory over breast cancer Mar 17, 2006
Yorkshire Post Today, ...monthly checkups. She is half way through a year's course of Herceptin and is also taking the drug Arimidex until 2009. Through ...
Thomson Scientific Names 'Red-Hot' Research Papers of 2005 Mar 20, 2006
International News Service, ...et al. (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer". By ...
Why life is seat Mar 17, 2006
Leeds Today, She is half way through a year's course of Herceptin – described as the magic bullet against cancer – and will also be taking the drug Arimidex until 2009. ...
Thomson Scientific Names 'Red-Hot' Research Papers of 2005 Mar 20, 2006
PR Newswire (press release), ...dosage vitamin E Internal supplementation may Medicine increase all-cause mortality" 10 A. Howell, "Results of the ATAC Lancet 69 et al. (Arimidex, Tamoxifen ...
HEALTH CALENDAR Mar 14, 2006
Detroit Free Press, Hospital's breast cancer education and support group will feature a representative from AstraZeneca Oncology speaking on the aromatase inhibitor Arimidex, 7-9 ...
NCCN Announces Important Updates to Ovarian Cancer Clinical ... Mar 6, 2006
Genetic Engineering News, Guidelines panel broadened the listing of acceptable recurrence modalities for ovarian cancer to include anastrazole (Arimidex, AstraZeneca), bevacizumab ...
Healthy woman's cancer trial intrigue Mar 5, 2006
ic Wales, The 10-year Ibis II trial was launched to test anastrozole - also known as Arimidex - which has already been shown to be the most effective hormone treatment ...
Journalists Covering AstraZeneca Can Now Find Broadcast-Standard ... Mar 15, 2006
PharmaLive.com (press release), There is also video of breast cancer therapy Arimidex and mammogram procedure footage to promote early detection and prevention. ...
Manhattan Research Reveals Top Ten Consumer-Ranked Pharmaceutical ... Mar 7, 2006
PR Newswire (press release), R) v5.0 include the following: Abilify, Accupril, Actonel, Actos, Adderall, Advair, Allegra, Amaryl, Ambien, Androgel, Aricept, Arimidex, Avandia, Avastin ...
Take Your Pills, All Your Pills Mar 11, 2006
Gadsden Times (subscription), AstraZeneca, which sells tamoxifen under the brand name Nolvadex and another breast cancer drug, Arimidex, helped pay for a meeting of a group of cancer ...
New Drugs For Breast Cancer 21 Dec 2005
WFtv.com, ...estrogen. There are three AIs approved by the FDA including anastrozole (Arimidex), exemestane (Aromasin) and letrozole (Femara). ...
Arimidex provides better survival rate for post-menopausal women ... Dec 14, 2005
Channel News Asia, But a study in the US has found that the drug Arimidex, now used to treat early breast cancer in post-menopausal women, gives better results. ...
Benefit of Switching to Arimidex® After 2-3 Years of Tamoxifen ... Dec 13, 2005
Cancer Consultants (press release), A combined analysis of three large clinical trials has confirmed that switching to the aromatase inhibitor Arimidex (anastrozole) after 2-3 years of adjuvant ...
More Women Will Survive Breast Cancer With Arimidex (anastrozole) ... Dec 9, 2005
Finanzen.net, LONDON, December 9 /PRNewswire/ -- Breakthrough data show that Arimidex (anastrozole) is the first and only breast cancer drug in the 'aromatase inhibitor' (AI ...
ARIMIDEX(R) (anastrozole) Featured in Studies Evaluating Impact of ... Dec 9, 2005
Finanzen.net, 9 /PRNewswire-FirstCall/ -- Studies presented today at the San Antonio Breast Cancer Symposium analyze the AstraZeneca drug ARIMIDEX(R) (anastrozole) in terms ...
New Data Show Survival Benefit for Arimidex(TM) in Early Breast ... Dec 9, 2005
news aktuell (Pressemitteilung), Macclesfield, England (ots/PRNewswire) - - Replacing tamoxifen With Arimidex (TM) (anastrozole) Shown to Reduce Patient's Risk of Death by Nearly a Third ...
New Data Show Survival Benefit for Arimidex(TM) in Early Breast ... Dec 9, 2005
PR Newswire (press release), ...- Replacing tamoxifen With Arimidex(TM) (anastrozole) Shown to Reduce Patient's Risk of Death by Nearly a Third MACCLESFIELD, England, Dec. ...
Data Show Survival Benefit For Arimidex In Early Breast Cancer Dec 9, 2005
PharmaLive.com (press release), Data presented today at the San Antonio Breast Cancer Symposium (SABCS), Texas has found that 'Arimidex' (anastrozole) is the first aromatase inhibitor (AI) to ...
New Data Show Survival Benefit for Arimidex(TM) in Early .... Dec 9, 2005
Nieuwsbank (persbericht), Breakthrough new data presented today show breast cancer treatment 'Arimidex' (anastrozole) is the first aromatase inhibitor (AI) to provide an overall ...
Breakthrough survival data on Arimidex® released Dec 11, 2005
Scoop.co.nz (press release), The results of the latest study, carried out in women who had already taken tamoxifen for two years, show that replacing tamoxifen with anastrozole for the ...
Survival Benefit For Arimidex™ In Early Breast Cancer Dec 11, 2005
Medical News Today (press release), Data presented at the San Antonio Breast Cancer Symposium (SABCS), Texas has found that 'Arimidex' (anastrozole) is the first aromatase inhibitor (AI) to ...
SABCS: A Switch to Arimidex After Two Years of Tamoxifen Improves ... Dec 10, 2005
MedPage Today, ...as adjuvant breast cancer therapy can improve their chances of a lengthy survival by 29% if they switch to the aromatase inhibitor Arimidex (anastrozole) after ...
SABCS: Ki67 Level Two Weeks After Starting Arimidex Predicts ... Dec 10, 2005
MedPage Today, 10 - Within two weeks of starting treatment with the aromatase inhibitor Arimidex (anastrozole) as adjuvant therapy for breast cancer, a well-known cellular ...
AstraZeneca Up Post Arimidex Presentation Dec 12, 2005
New Ratings 1208 GMT [Dow Jones] AstraZeneca (AZN.ISE) +0.3% at 2,732p post presentation of Arimidex data at the San Antonio breast cancer symposium in Texas. ...
Study Confirms Superiority of Switching to Arimidex® Following 2 ... Dec 12, 2005
Cancer Consultants (press release), A meta-analysis from three large randomized trials has confirmed that switching to the aromatase inhibitor Arimidex (anastrozole) following 2-3 years of ...
Anastrozole (Arimidex) Outperforms Tamoxifen Dec 5, 2005
CancerWise The drug anastrozole (Arimidex®) now replaces tamoxifen as the recommended treatment to help prevent recurrence of breast cancer in postmenopausal women with ...
(PRN) Analysis Demonstrates Time to Response With FASLODEX(R) ... Dec 10, 2005
Houston Chronicle, An analysis of two Phase III studies evaluating time to response (TTR) with FASLODEX(R) (fulvestrant) Injection compared to ARIMIDEX(R) (anastrozole) as ...
Breast cancer drug may work in lung cancer Dec 16, 2005
Science Daily (press release) 16 (UPI) -- Breast cancer drug Anastrozole, sold as Arimidex, may also inhibit the growth of lung cancer, say researchers at Vanderbilt University in the ...
Breast cancer drug may work in lung cancer Dec 16, 2005
Monsters and Critics.com, WASHINGTON, DC, United States (UPI) -- Breast cancer drug Anastrozole, sold as Arimidex, may also inhibit the growth of lung cancer, say researchers at ...
Health campaigns face axe in cash crisis Dec 10, 2005
The Sunday Times, The National Institute for Health and Clinical Excellence (Nice) is under pressure to carry out a special analysis of Arimidex after trials revealed that it ...
Plenary Session Snapshot Dec 19, 2005
Medscape (subscription) ...agents have been developed that inhibit it. Arimidex (anastrozole) is one of these agents. Is it possible to identify patients with ...
New breast cancer drug cuts death rate Dec 11, 2005
New Zealand Herald, ...the San Antonio breast cancer symposium in Texas last week showed benefits in replacing Tamoxifen - the "gold standard" drug treatment - with Arimidex for post ...
New cancer drug puts NHS under pressure Dec 9, 2005
Guardian Unlimited, ...be given to the NHS in England and Wales on the overall effectiveness and value for money of anastrozole - marketed by AstraZeneca as Arimidex - or similar ...
NHS under pressure to provide new breast cancer drugs Dec 12, 2005
News-Medical.net, ...is expected to be given to the NHS in the UK on the overall effectiveness and value for money of anastrozole, marketed by AstraZeneca as Arimidex, or similar ...
New cancer drug puts pressure on NHS Dec 12, 2005
myDNA.com, ...study involving 4,000 postmenopausal women with hormone-sensitive early breast cancer found that those who were treated with Arimidex (anastrozole) instead of ...
New strategy for boosting breast cancer survival Dec 9, 2005
MSNBC ...does. Three brands are available: AstraZeneca PLC’s Arimidex, Pfizer Inc.’s Aromasin and Novartis Pharmaceuticals’ Femara. ...
A switch in cancer drugs could extend women's lives Dec 9, 2005
Houston Chronicle, ...tamoxifen does. Three brands are available: AstraZeneca's Arimidex, Pfizer's Aromasin and Novartis Pharmaceuticals' Femara. Doctors ...
Study shows increased breast cancer survival rates on alternative ... Dec 9, 2005
Newstalk ZB, The international study shows risk of death is reduced by 30 percent when post-menopausal breast cancer sufferers switch from Tamoxifen to Arimidex. ...
Study indicates continued breast-cancer treatment helps Dec 10, 2005
Kansas.com, ...does. Three brands are available: AstraZeneca PLC's Arimidex, Pfizer Inc.' s Aromasin and Novartis Pharmaceuticals' Femara. Doctors ...
NHS under pressure to broaden access for new breast cancer drug Dec 11, 2005
viploan.co.uk, ...given two years after Tamoxifen. The drug Arimidex is currently available for selective use after surgery. It belongs to a class ...
Survival Advantage of Anastrozole over Tamoxifen Seen in Meta ... Dec 12, 2005
DG News ...the first time, doctors say that switching a breast cancer patient from the gold standard tamoxifen to the aromatase inhibitor anastrozole (Arimidex) can save ...
(PRN) - Creighton Corp. Completes Merger with Pearlstar ... Dec 9, 2005
Bolsamania.com, ...[+]. (PRN) - ARIMIDEX(R) (anastrozole) Featured in Studies Evaluating Impact of Switching on Survival in Adjuvant Treatment of Early Breast Cancer ... [+. ...
Breast Cancer Treatment Dec 16, 2005
Food Consumer, Arimidex, tamoxifen alone or in combination.: Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of ...
Study: Breast cancer drug switch may improve odds Dec 11, 2005
Chicago Tribune, Researchers led by Dr. Walter Jonat of the University of Kiel in Germany combined information from three European studies on Arimidex, one brand of aromatase ...
Femara gets approval for early adjuvant use in UK Dec 8, 2005
Pharma Times (subscription), This profile should aid Femara as it competes with the other main aromatase inhibitors, AstraZeneca's Arimidex (anastrozole) and Pfizer's Aromasin (exemestane ...
Cancer survivor battles illness without aid of health benefits Dec 13, 2005
Reno Gazette Journal, ...months. Without that help, she can't afford the $310 necessary every month to fill her prescription of Arimidex, an anti-cancer drug. ...
UK okays early use of Novartis breast cancer drug Dec 7, 2005
Scotsman, ...licence approval is ahead of the rest of Europe and the United States, and follows a similar green light for AstraZeneca Plc's rival product, Arimidex, in June ...
UK okays early use of Novartis breast cancer drug Dec 7, 2005
Reuters ...rest of Europe and the United States, and follows a similar green light for AstraZeneca Plc's (AZN.L: Quote, Profile, Research) rival product, Arimidex, in June ...
Survival gain seen with breast-cancer drug Dec 9, 2005
United Press International Austrian study that compared outcomes between postmenopausal women taking either tamoxifen or the aromatase inhibitor anastrozole (Arimidex) following surgery ...
Fewer Gynecological Problems Seen in Women on Anastrozole in ATAC ... Dec 12, 2005
DG News In the Arimidex, Tamoxifen Alone or in Combination (ATAC) Trial, anastrozole therapy reduced the risk of breast cancer recurrence better than tamoxifen. ...
Knowing Vital to Cancer Care Nov 29, 2005
The Ledger, How many breast cancer survivors now taking an aromatase inhibitor like Arimidex know that their risk of developing osteoporosis and fractures is increased as ...
Modern world embraces acupuncture Nov 29, 2005
DetNews.com, ...menopausal breast cancer patients who have completed chemotherapy and are receiving hormonal therapy with either the anti-estrogen drug Tamoxifen or Arimidex. ...
Pfizer's Troubles Pull Down Drugmakers Nov 21, 2005
Chemical & Engineering News ...driven by five key products: the ulcer drug Nexium, the cholesterol-reducing agent Crestor, the asthma treatment Symbicort, the oncology drug Arimidex, and the ...
AstraZeneca Provides Additional Support to Hurricane Victims Nov 17, 2005
PR Newswire (press release), These medicines include: ACCOLATE(R) (zafirlukast), ARIMIDEX(R) (anastrozole), ATACAND(R) (candesartan cilexetil), ATACAND HCT(R) (candesartan cilexetil ...
|
|
